What's new

Human medicines European public assessment report (EPAR): Kinpeygo, budesonide, Date of authorisation: 15/07/2022, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Kinpeygo, budesonide, Date of authorisation: 15/07/2022, Revision: 11, Status: Authorised

Feb 11, 2025 - 15:30
 0
Human medicines European public assessment report (EPAR): Kinpeygo, budesonide, Date of authorisation: 15/07/2022, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Kinpeygo, budesonide, Date of authorisation: 15/07/2022, Revision: 11, Status: Authorised
Read More

Tags:

Previous Article

BJ’s Wholesale Club to open distribution center in Ohio

Next Article

Hugo Boss renews childrenswear license with CWF until 2029

Related Posts

Quality Working Party

Quality Working Party

Feb 9, 2025  0

List of centrally authorised products with safety-relat...

Feb 28, 2025  0

Human medicines European public assessment report (EPAR): Cimzia, certolizumab pegol, Date of authorisation: 01/10/2009, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 18, 2025  0